Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Nov 15;16(22):3904.
doi: 10.3390/nu16223904.

Evaluating the Screening Capability of the SarQoL Questionnaire in Sarcopenic Obesity: A Comparison Study Between Spanish and Belgian Community-Dwelling Older Adults

Angela Diago-Galmés  1 , Carlos Guillamón-Escudero  2 , Jose M Tenías-Burillo  3 , Jose M Soriano  4   5 , Julio Fernandez-Garrido  6
Affiliations
Comparative Study

Evaluating the Screening Capability of the SarQoL Questionnaire in Sarcopenic Obesity: A Comparison Study Between Spanish and Belgian Community-Dwelling Older Adults

Angela Diago-Galmés et al. Nutrients. .

Abstract

Background/objectives: This study aims to evaluate the potential of the SarQoL questionnaire as a screening tool for sarcopenic obesity by comparing its effectiveness in Spanish and Belgian community-dwelling older people. This research seeks to address the primary question of whether the SarQoL can reliably differentiate quality of life impacts between these groups.

Methods: A cross-sectional study was conducted involving community-dwelling older adults from Valencia (Spain) and Liège (Belgium). Participants were assessed using the SarQoL questionnaire, which measures health-related quality of life specifically for sarcopenia, and a sarcopenic obesity diagnostic method based on a combination of the EWGSOP2 criteria for sarcopenia and of body mass index for obesity. The sample included diverse demographic and clinical characteristics to ensure comprehensive analysis. Statistical methods were employed to compare the outcomes between the two populations.

Results: The study highlighted a significant relationship between quality-of-life scores and the prevalence of sarcopenic obesity in the Spanish and Belgian populations. The SarQoL questionnaire effectively identified lower quality of life in individuals with sarcopenic obesity, demonstrating its potential as a reliable screening tool across different populations. In conclusion, the SarQoL questionnaire proved to be an effective tool for evaluating quality of life and for screening individuals with sarcopenic obesity.

Conclusions: Future research should prioritize longitudinal studies to determine the SarQoL questionnaire's predictive value and investigate interventions to alleviate the adverse effects of sarcopenic obesity. Our results highlight the critical need to include quality of life assessments in managing sarcopenic obesity, advocating for a comprehensive approach to patient care.

Keywords: SarQoL; older adults; quality of life; sarcopenic obesity; screening method.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Algorithm for sarcopenic obesity diagnosis.
Scheme 1
Scheme 1
Visual representation of the significance of the relationships between principal variables involved in the diagnosis of sarcopenic obesity and SarQoL domains/total score. a Appendicular skeletal muscle mass. b Body mass index.
Figure 2
Figure 2
Sarcopenic obesity risk based on SarQoL questionnaire scores, assessing sensibility and specificity for the obtained results.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Roubenoff R. Sarcopenic obesity: The confluence of two epidemics. Obes. Res. 2004;12:887–888. doi: 10.1038/oby.2004.107. - DOI - PubMed
    1. Prado C.M.M., Wells J.C.K., Smith S.R., Stephan B.C.M., Siervo M. Sarcopenic obesity: A Critical appraisal of the current evidence. Clin. Nutr. 2012;31:583–601. doi: 10.1016/j.clnu.2012.06.010. - DOI - PubMed
    1. Johnson Stoklossa C.A., Sharma A.M., Forhan M., Siervo M., Padwal R.S., Prado C.M. Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria. J. Nutr. Metab. 2017;2017:7307618. doi: 10.1155/2017/7307618. - DOI - PMC - PubMed
    1. Cruz-Jentoft A.J., Bahat G., Bauer J., Boirie Y., Bruyère O., Cederholm T., Cooper C., Landi F., Rolland Y., Sayer A.A., et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi: 10.1093/ageing/afy169. - DOI - PMC - PubMed
    1. Kalinkovich A., Livshits G. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res. Rev. 2017;35:200–221. doi: 10.1016/j.arr.2016.09.008. - DOI - PubMed

Publication types

LinkOut - more resources